skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Search For:
Clear Search Box
Search in:
Busca Geral
Or select another collection:
Search in:
Busca Geral
Busca Avançada
Busca por Índices
This feature requires javascript
This feature requires javascript
Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Andriole, Gerald L.
Prostate Cancer Prevention, 2014, Vol.202, p.53-57
[Periódico revisado por pares]
Germany: Springer Berlin / Heidelberg
Sem texto completo
Citações
Citado por
Serviços
Detalhes
Resenhas & Tags
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Autor:
Andriole, Gerald L.
Assuntos:
Aged
;
Colorectal Neoplasms - diagnosis
;
Colorectal Neoplasms - prevention & control
;
Female
;
Follow-Up Studies
;
Healthy Volunteer Effect
;
Humans
;
Incidence
;
Lung Neoplasms - diagnosis
;
Lung Neoplasms - prevention & control
;
Male
;
Mass Screening - methods
;
Middle Aged
;
Mortality - trends
;
Multicenter Studies as Topic
;
Oncology
;
Outcome Assessment (Health Care) - methods
;
Outcome Assessment (Health Care) - statistics & numerical data
;
Ovarian Neoplasms - diagnosis
;
Ovarian Neoplasms - prevention & control
;
PLCO Trial
;
Prostate Cancer-specific Mortality
;
Prostate, Lung, Colorectal And Ovarian (PLCO)
;
Prostate-Specific Antigen - blood
;
Prostatic Neoplasms - diagnosis
;
Prostatic Neoplasms - mortality
;
Prostatic Neoplasms - prevention & control
;
Prostatic Portion
;
Randomized Controlled Trials as Topic
;
United States - epidemiology
;
Urology & urogenital medicine
É parte de:
Prostate Cancer Prevention, 2014, Vol.202, p.53-57
Notas:
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição:
The prostate portion of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial began in the early 1990s to assess the ability of annual PSA and DRE to reduce prostate cancer specific mortality in men aged 55–74. Approximately 80,000 men have been randomized and followed for a minimum of 13 years. Thus far, annual screening in this study has not been associated with a reduction of prostate cancer specific mortality. The potential explanations for this finding are reviewed.
Títulos relacionados:
Recent Results in Cancer Research
Editor:
Germany: Springer Berlin / Heidelberg
Idioma:
Inglês
Links
View this record in MEDLINE/PubMed
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
Anterior
Resultado
9
Avançar
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_PRODUCAO),scope:(USP_EBOOKS),scope:("PRIMO"),scope:(USP),scope:(USP_EREVISTAS),scope:(USP_FISICO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript